Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

Retention Strategies for Medications for Addiction Treatment in Adults With Opioid Use Disorder

About this resource:

HHS Non-systematic Review

Source: Agency for Healthcare Research and Quality

Last Reviewed: August 2020

In this rapid evidence review, researchers looked at systematic reviews and randomized controlled trials to summarize evidence on the effectiveness of interventions involving medications for addiction treatment (MAT) in adults with opioid use disorder. They found that people who get longer-term MAT treatment have better outcomes but noted that fewer than half of the studies in their review measured treatment retention as a primary outcome. They also looked at the effectiveness of specific medicines and at the effects of combining MAT with other services.

Read more about this resource

Objectives related to this resource (2)

Suggested Citation

1.

Chan B, Gean E, Arkhipova-Jenkins I, et al. (2020) Retention Strategies for Medications for Addiction Treatment in Adults With Opioid Use Disorder: A Rapid Evidence Review. AHRQ Publication No. 20-EHC012. Retrieved from https://effectivehealthcare.ahrq.gov/products/retention-strategies-opioid-use-disorder/rapid-research